INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $30,000 | -36.2% | 57,534 | -4.8% | 0.00% | – |
| Q4 2017 | $47,000 | -45.3% | 60,430 | +1.4% | 0.00% | – |
| Q3 2017 | $86,000 | -46.6% | 59,573 | -0.0% | 0.00% | – |
| Q2 2017 | $161,000 | -88.3% | 59,587 | -82.5% | 0.00% | – |
| Q1 2017 | $1,378,000 | -4.5% | 340,126 | -1.1% | 0.00% | – |
| Q4 2016 | $1,443,000 | -38.5% | 343,749 | -0.4% | 0.00% | -100.0% |
| Q3 2016 | $2,347,000 | +18.7% | 345,152 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $1,978,000 | +0.7% | 342,141 | +21.6% | 0.00% | 0.0% |
| Q1 2016 | $1,965,000 | -1.8% | 281,414 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $2,002,000 | -14.5% | 278,109 | +2.4% | 0.00% | 0.0% |
| Q3 2015 | $2,342,000 | +151.3% | 271,715 | +371.3% | 0.00% | – |
| Q2 2015 | $932,000 | – | 57,657 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|